Poster exhibition
Adaptive immunity

Programme

• • Poster
  • P 001

  Population-based study of the durability of humoral immunity after SARS-CoV-2 infection

  • Dr. David Peterhoff (Regensburg / DE)

   Adaptive immunity
• • Poster
  • P 002

  Pre-existing flavivirus immunity reshapes the immunodominance and impacts the immunogenicity of the yellow fever vaccine

  • Antonio Santos-Peral (Munich / DE)

   Adaptive immunity
• • Poster
  • P 003

  Modulation of friend virus-specific CD4+ T cell responses by different IFNα subtypes

  • Mara Schwerdtfeger (Essen / DE)

   Adaptive immunity, Innate immunity
• • Poster
  • P 005

  Differences in cross-reactive IgG responses after flavivirus infections

  • Lena Roßbacher (Vienna / AT)

   Adaptive immunity, Diagnostic methods and tools
• • Poster
  • P 006

  SARS-CoV-2 pulmonary infection and CD4⁺ T cell responses of Jamaican fruit bats using Adenovirus-transduced human ACE2

  • Professor Tony Schountz (Fort Collins, CO / US)

   Adaptive immunity
• • Poster
  • P 007

  Generation and functional analysis of spacer modified HBV-specific chimeric antigen receptors that harbor a Fab fragment as binding domain

  • Zhe Xie (Munich / DE)

   Adaptive immunity, Antiviral therapy and resistance
• • Poster
  • P 008

  COVIDYS: Post-COVID patients recognize different epitopes within the SARS-CoV-2 S-protein compared to a convalescent control group – a new biomarker?

  • Clara Luzia Magnus (Regensburg / DE)

   Adaptive immunity
• • Poster
  • P 009

  T cell receptor clonotypes of two epitope-specific CD8+ T cell responses in chronically LCMV infected mice revealed heterogeneous phenotypes on a single-cell level

  • Dr. Sebastian Klein (Hannover / DE)

   Adaptive immunity
• • Poster
  • P 010

  Early nucleocapsid-specific T cell responses associate with control of SARS-CoV-2 in the upper airways and reduced systemic inflammation before seroconversion

  • Tabea Eser (Munich / DE)

   Adaptive immunity
• • Poster
  • P 011

  Comparative analysis of vaccine-induced neutralizing antibodies against the Alpha, Beta, Delta and Omicron variants of SARS-CoV-2

  • Dr. Katharina Müller (Munich / DE)

   Adaptive immunity
• • Poster
  • P 012

  CD8+ T cell mediated protection against Zika virus induced by recombinant modified Vaccinia virus Ankara expressing ZIKV non-structural protein NS2B

  • Sabrina Clever (Hannover / DE)

   Adaptive immunity
• • Poster
  • P 013

  The viral pUL11 protein exploits inhibitory functions of the CD45 receptor to impair T cell control of HCMV infection

  • Penelope Kay-Fedorov (Hannover / DE)

   Adaptive immunity, Host cell factors and modulation
• • Poster
  • P 014

  SARS-CoV-2 strongly downregulates MHC class I

  • Ivo Schirmeister (Freiburg / DE)

   Adaptive immunity
• • Poster
  • P 015

  High-dimensional clustering of B cell receptor sequences shows convergent repertoires in SARS-CoV-2 RBD repertoires

  • Dr. Emanuel Wyler (Berlin / DE)

   Adaptive immunity, SARS-CoV-2
• • Poster
  • P 016

  Presence of a functional purinergic receptor in MVA infected feeder cells enhances antigen cross-presentation

  • Ylenia Longo (Duesseldorf / DE)

   Adaptive immunity, Host cell factors and modulation
• • Poster
  • P 017

  Identification of HCMV encoded antagonists of adaptive NK cell expansion

  • Magdalena Huber (Freiburg / DE)

   Adaptive immunity
• • Poster
  • P 018

  SARS-CoV-2 vaccination of convalescents boosts neutralization capacity against SARS-CoV-2 Omicron BA.1, BA.2 and BA.5 that can be predicted by anti-Spike antibody concentrations in serological assays

  • Alina Seidel (Ulm / DE)

   Adaptive immunity